A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Compare the Efficacy and Safety of Three Doses of Botulinum Toxin Type A (Dysport) With Placebo in Upper Limb Spasticity After Stroke
暂无分享,去创建一个
Werner Poewe | Reiner Benecke | A. Thilmann | W. Poewe | J. Wissel | R. Benecke | C. Collin | A. Bakheit | A. Ward | J. Muller | F. Muller | C. Ward | C. Neumann | A. F. Thilmann | Jörg Wissel | A. M. O. Bakheit | A. B. Ward | J. Muller | C. Collin | F. Muller | C. D. Ward | C. Neumann | R. Benecke | R. Benecke | W. Poewe | J. Wissel | J. Wissel
[1] S. Hesse,et al. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial , 1998, Clinical rehabilitation.
[2] D. Mclellan,et al. The effectiveness of chemical neurolysis in the treatment of lower limb muscle spasticity , 1996 .
[3] E. Tichauer. Anatomic Guide for the Electromyographer , 1977 .
[4] C. Poulos,et al. Objective assessment of spasticity, strength, and function with early exhibition of dantrolene sodium after cerebrovascular accident: a randomized double-blind study. , 1992, Archives of physical medicine and rehabilitation.
[5] R. Angel,et al. Impairment of voluntary movement by spasticity , 1979, Annals of neurology.
[6] K. Aho,et al. Cerebrovascular disease in the community: results of a WHO collaborative study. , 1980, Bulletin of the World Health Organization.
[7] N. Lincoln,et al. Assessment of motor function in stroke patients. , 1979, Physiotherapy.
[8] D. Wade,et al. The Barthel ADL Index: a reliability study. , 1988, International disability studies.
[9] C. Wiles,et al. A timed test of swallowing capacity for neurological patients. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[10] Richard W. Bohannon,et al. Interrater reliability of a modified Ashworth scale of muscle spasticity. , 1987, Physical therapy.
[11] T K Das,et al. Effect of treatment with botulinum toxin on spasticity. , 1989, Postgraduate medical journal.
[12] B. Bhakta,et al. Use of botulinum toxin in stroke patients with severe upper limb spasticity. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[13] H. Hjaltason,et al. A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport® and Botox®in the treatment of cervical dystonia , 1998, Journal of neurology, neurosurgery, and psychiatry.
[14] D. M. Simpson,et al. Botulinum toxin type A in the treatment of upper extremity spasticity , 1996, Neurology.
[15] M. Cowan,et al. American Heart Association. , 2018, P & T : a peer-reviewed journal for formulary management.